These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 3022676)

  • 1. Intraductal carcinoma. Analysis of presentation, pathologic findings, and outcome of disease.
    Schuh ME; Nemoto T; Penetrante RB; Rosner D; Dao TL
    Arch Surg; 1986 Nov; 121(11):1303-7. PubMed ID: 3022676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast carcinoma in situ in 167 women--incidence, mode of presentation, therapy and follow-up.
    Ringberg A; Andersson I; Aspegren K; Linell F
    Eur J Surg Oncol; 1991 Oct; 17(5):466-76. PubMed ID: 1657650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paget's disease of the nipple with parenchymal ductal carcinoma in situ is associated with worse prognosis than Paget's disease alone.
    Durkan B; Bresee C; Bose S; Phillips EH; Dang CM
    Am Surg; 2013 Oct; 79(10):1009-12. PubMed ID: 24160789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological Follow-up of Breast DCIS Diagnosed on Biopsies: A Single Institutional Study of 575 Patients.
    Yan M; Bomeisl P; Gilmore H; Harbhajanka A
    Int J Surg Pathol; 2021 Dec; 29(8):836-843. PubMed ID: 33890815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel node procedure is warranted in ductal carcinoma in situ with high risk of occult invasive carcinoma and microinvasive carcinoma treated by mastectomy.
    Tunon-de-Lara C; Giard S; Buttarelli M; Blanchot J; Classe JM; Baron M; Monnier B; Houvenaeghel G
    Breast J; 2008; 14(2):135-40. PubMed ID: 18315691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microinvasive breast carcinoma: clinicopathologic analysis of a single institution experience.
    Padmore RF; Fowble B; Hoffman J; Rosser C; Hanlon A; Patchefsky AS
    Cancer; 2000 Mar; 88(6):1403-9. PubMed ID: 10717623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases.
    Goyal A; Douglas-Jones A; Monypenny I; Sweetland H; Stevens G; Mansel RE
    Breast Cancer Res Treat; 2006 Aug; 98(3):311-4. PubMed ID: 16552627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary?
    Foster MC; Helvie MA; Gregory NE; Rebner M; Nees AV; Paramagul C
    Radiology; 2004 Jun; 231(3):813-9. PubMed ID: 15105449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of invasive breast cancer in mammographically detected microcalcification in patients with a core biopsy diagnosis of flat epithelial atypia, atypical ductal hyperplasia or ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy.
    Catteau X; Simon P; Noël JC
    Pathol Res Pract; 2012 Apr; 208(4):217-20. PubMed ID: 22445178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor size as predictor of microinvasion, invasion, and axillary metastasis in ductal carcinoma in situ.
    Maffuz A; Barroso-Bravo S; Nájera I; Zarco G; Alvarado-Cabrero I; Rodríguez-Cuevas SA
    J Exp Clin Cancer Res; 2006 Jun; 25(2):223-7. PubMed ID: 16918134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of microinvasion on axillary node metastases and survival in patients with intraductal breast cancer.
    Wong JH; Kopald KH; Morton DL
    Arch Surg; 1990 Oct; 125(10):1298-301; discussion 1301-2. PubMed ID: 2171453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In situ ductal carcinoma of the breast--analysis of clinical presentation and outcome in 156 consecutive cases.
    Ciatto S; Grazzini G; Iossa A; Del Turco MR; Bravetti P; Cataliotti L; Cardona G; Bianchi S
    Eur J Surg Oncol; 1990 Jun; 16(3):220-4. PubMed ID: 2161353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors predicting microinvasion in Ductal Carcinoma in situ.
    Ozkan-Gurdal S; Cabioglu N; Ozcinar B; Muslumanoglu M; Ozmen V; Kecer M; Yavuz E; Igci A
    Asian Pac J Cancer Prev; 2014; 15(1):55-60. PubMed ID: 24528005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI accurately depicts underlying DCIS in a patient with Paget's disease of the breast without palpable mass and mammography findings.
    Amano G; Yajima M; Moroboshi Y; Kuriya Y; Ohuchi N
    Jpn J Clin Oncol; 2005 Mar; 35(3):149-53. PubMed ID: 15741305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ductal carcinoma in situ: value of sentinel lymph node biopsy.
    Sakr R; Barranger E; Antoine M; Prugnolle H; Daraï E; Uzan S
    J Surg Oncol; 2006 Oct; 94(5):426-30. PubMed ID: 16967457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk predictors of underestimation and the need for sentinel node biopsy in patients diagnosed with ductal carcinoma in situ by preoperative needle biopsy.
    Park HS; Park S; Cho J; Park JM; Kim SI; Park BW
    J Surg Oncol; 2013 Mar; 107(4):388-92. PubMed ID: 23007901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit.
    Moore KH; Sweeney KJ; Wilson ME; Goldberg JI; Buchanan CL; Tan LK; Liberman L; Turner RR; Lagios MD; Cody Iii HS; Giuliano AE; Silverstein MJ; Van Zee KJ
    Ann Surg Oncol; 2007 Oct; 14(10):2911-7. PubMed ID: 17597346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast ductal carcinoma in situ with microinvasion: a definition supported by a long-term study of 1248 serially sectioned ductal carcinomas.
    de Mascarel I; MacGrogan G; Mathoulin-Pélissier S; Soubeyran I; Picot V; Coindre JM
    Cancer; 2002 Apr; 94(8):2134-42. PubMed ID: 12001109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of ductal carcinoma in situ with nipple discharge. Intraductal spreading of carcinoma is an unfavorable pathologic factor for breast-conserving surgery.
    Ohuchi N; Furuta A; Mori S
    Cancer; 1994 Aug; 74(4):1294-302. PubMed ID: 8055451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel lymph node biopsy is not necessary in patients diagnosed with ductal carcinoma in situ of the breast by stereotactic vacuum-assisted biopsy.
    Kotani H; Yoshimura A; Adachi Y; Ishiguro J; Hisada T; Ichikawa M; Gondou N; Hattori M; Kondou N; Sawaki M; Fujita T; Iwata H
    Breast Cancer; 2016 Mar; 23(2):190-4. PubMed ID: 24989112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.